SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (14054)2/2/1998 8:53:00 AM
From: CYBERKEN  Read Replies (2) of 32384
 
Perhaps Ligand's earlier-stage pipeline projects development could be accellerated by new potential alliances. Hopefully the new deals could more easily be made for greater up-front cash payments and better royalty splits-rather than equity sales (even at a premium). Could we see a deal or 2 in the 2nd half that would make the Lilly alliance look like a givaway? At the very least, Ligand should have much more leverage regarding up-front cash.

Ligand at this point has shown superiority in 2 aspects of the business: Creating new products to add to it's pipeline, and conducting clinicals rapidly and with little error. Those 2 capabilities could be selling at much greater premiums soon.

The prospect of this could affect the stock price before 2H, given the usual caveat that the street has to figure this out. The signposts seem to be getting bigger each day.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext